This is definitely true, and something med students may be cognizant of, but it's tied to a larger and more important problem, which is reimbursement and our role within the delivery of healthcare. We are ancillary providers that have zero patient contact (ie. no patient satisfaction scores), our work can be easily outsourced to save on the bottom line, and with the exception of dermpath, we are entirely reliant on hospitals and other providers to submit specimens to us. This last part may be similar to other specialties in a sense, such as radiology, but aside from some orthos owning imaging machines and employing radiologists, no other specialty is so entrenched in kickbacks and bottom feeding as pathology. Derm...gastro...urology...all view pathology as a cog in their revenue wheel and make money hand over fist paying pathologists pennies on the dollar for the opportunity to read their specimens, all in the name of "business." Pathologists increasingly take such arrangements in the name of "volume" as our reimbursement has been whittled to a pittance the last 20 years, which also leads to an overutilization in special & immunohistochemical stains in practices that don't necessarily add value but help defray the loss of revenue from declining reimbursement, corporate competition, hospital acquisition, greedy dermatologists/urologists/gastroenterologists, etc.
Maybe US med students aren't savvy enough to extrapolate these nuances or see the writing on the wall, but they're hopefully coming to the same conclusion.